Breast cancer tumor size: correlation between magnetic resonance imaging and pathology measurements - 20/08/11
Abstract |
Background |
As physicians increasingly use magnetic resonance imaging (MRI) for the evaluation of newly diagnosed breast cancers, a review of the correlation between MRI and pathology tumor size is imperative.
Methods |
A retrospective review of 91 breast tumors comparing preoperative MRI tumor size to final pathology tumor size was performed.
Results |
MRI and pathology tumor size were positively correlated (R = .650), but with an average overestimation by MRI of .63 cm (P <.0001). When stratified by MRI tumor size (≤2.0 cm and >2.0 cm), a significant difference was found only in tumors greater than 2.0 cm (average overestimation = 1.06 cm; P <.0001). This trend continued for the histological subtypes of ductal carcinoma in situ (DCIS), invasive ductal carcinoma (IDC), and invasive lobular carcinoma (ILC).
Conclusions |
MRI tumor size correlates with pathology size; however, a significant overestimation exists, particularly for tumors >2.0 cm. Clinicians should therefore use caution in relying on MRI tumor size in determining candidacy for breast conservation therapy (BCT).
Le texte complet de cet article est disponible en PDF.Keywords : Breast cancer, Breast magnetic resonance imaging, Tumor size, Pathology
Plan
Vol 196 - N° 6
P. 844-850 - décembre 2008 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?